The effect of treating infected skin grafts with Acticoat on immune cells.
A study was conducted to determine the effect of Acticoat placed on an infected skin graft on parameters of immunity. Two partial thickness wounds (2 cm x 4 cm) were created on the dorsal midline of Hartley guinea pigs (n=28). Wounds were covered with autologous skin graft and maintained either aseptically (Noninoculated, n=8), inoculated with Staphylococcus aureus (Surgery-Inoculated, n=8) with or without Acticoat bandage (Surgery-Inoculated-Acticoat, n=6). Five days later, splenocytes and blood were collected to estimate natural killer cell (NK) cytotoxicity, proliferative response to T and B cell mitogens and neutrophil oxidative burst. Animals that did not undergo surgery were included as a nonsurgery control group. [(3)H]-thymidine incorporation in response to a variety of T and B cell mitogens was significantly lower for all groups undergoing surgery compared to the nonsurgery control group (p<0.0001) and no additional effect was observed on this immune measure by applying the Acticoat bandage. The Surgery-Inoculated-Acticoat group exhibited greater NK cytotoxic activity (as assessed as the ability to lyse K562 tumor cells) compared to the Surgery-Inoculated group (p<0.006). The Surgery-Inoculated-Acticoat group had higher neutrophil oxidative burst at 5 min post stimulation, but was not different from controls after 15 min. In conclusion, the application of an Acticoat bandage to an inoculated surgery wound did not alter the low cell-mediated immune response that followed surgery, but appeared to increase parameters (NK cytotoxic activity and neutrophil function) of innate immunity.
Mazurak
Vera C
VC
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alta., Canada T6G 2P5. vera.mazurak@ualberta.ca
Burrell
Robert E
RE
Tredget
Edward E
EE
Clandinin
M Thomas
MT
Field
Catherine J
CJ
D000818:Animals; D002056:Burns / Q000628:therapy*; D006168:Guinea Pigs; D007694:Killer Cells, Natural; D009504:Neutrophils / Q000276:immunology; D011091:Polyesters / Q000627:therapeutic use*; D011095:Polyethylenes / Q000627:therapeutic use*; D016897:Respiratory Burst; D016038:Skin Transplantation / Q000276:immunology / Q000379:methods; D013207:Staphylococcal Skin Infections / Q000276:immunology / Q000628:therapy*; D013211:Staphylococcus aureus; D013530:Surgical Wound Infection / Q000276:immunology / Q000628:therapy*
C117408:Acticoat; D011091:Polyesters; D011095:Polyethylenes